Format

Send to

Choose Destination
Drug Des Devel Ther. 2015 Apr 9;9:2079-88. doi: 10.2147/DDDT.S78757. eCollection 2015.

Management of severe sepsis: advances, challenges, and current status.

Author information

1
Multidisciplinary Intensive Care Research Organization (MICRO), St James's University Hospital, Trinity Centre for Health Sciences, Dublin, Ireland.
2
Brown University, Providence, RI, USA.
3
Critical Care Center, CIBER Enfermedades Respiratorias, Sabadell Hospital, Corporació Sanitaria Universitaria Parc Tauli, Autonomous University of Barcelona, Barcelona, Spain.

Abstract

The complexity of treating severe sepsis and septic shock has been elucidated in myriad studies, particularly in the past 10 years. The development of clinical guidelines, insight into the effect of bundle elements, and results of clinical trials have brought to light further opportunities and questions in the approach to pharmaceutical interventions for the global challenge to save lives and reduce healthcare costs. Therapeutic interventions including fluid resuscitation, hemodynamic monitoring, glycemic control, corticosteroids, and antimicrobial therapy and stewardship inform outcomes. Research on biomarkers, use of mesenchymal stem cells, blood purification, immunoglobulins, and antioxidative treatments apropos the immune response may soon yield viable therapies.

KEYWORDS:

biomarkers; critical care; guidelines; sepsis; septic shock; surviving sepsis campaign

PMID:
25926718
PMCID:
PMC4403600
DOI:
10.2147/DDDT.S78757
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Dove Medical Press Icon for PubMed Central
Loading ...
Support Center